Question · Q4 2025
David Silver asked for details on the production reductions at Millsdale and the UK facility (Stalybridge) as part of Project Catalyst, specifically if all affected areas were in commodity surfactants. He also questioned if the 2026 CapEx guidance represented a new base for sustaining CapEx or included discretionary/growth-oriented projects, and how Stepan is adapting to consumers trading down in personal care. Finally, he inquired about the impact of the global tariff situation on Stepan's asset competitiveness, particularly in Mexico, and the company's overall positioning.
Answer
Luis Rojo, President and CEO, confirmed that all Project Catalyst actions discussed were within the surfactants segment, involving ethoxylation assets at Millsdale (moving volume to Pasadena) and exiting a low-margin, high-CapEx organics business at Stalybridge. He explained that the 2026 CapEx guidance of $105-$115 million includes a normal base CapEx (under $100 million) plus some growth capital projects to support innovation. Rojo noted that Stepan is adapting to consumers trading down in personal care by focusing on Tier 2/3 customers and sulfate-free products. Regarding tariffs, he acknowledged a significant impact in 2025 from inflationary pressures and tariffs, stating that Stepan leverages its global production footprint and supply chain options to mitigate risks and will continue to evaluate opportunities, including seeking refunds for past tariffs.
Ask follow-up questions
Fintool can predict
SCL's earnings beat/miss a week before the call